Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Texts and tools could help liver transplant patients stay on track

NCT ID NCT05260268

Disease control Sponsor: University of Pennsylvania Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jul 16, 2026 · Updated 3 times

Summary

This study tests whether technology and caregiver support can help liver transplant recipients take their medications correctly. Researchers will enroll 360 adults who received a liver transplant within the past 3 months. Participants will use a system called Way to Health, which includes text messages and online tools, to improve medication adherence and health outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
behavioral intervention using the Way to Health system
What this could lead to
If successful, this could provide a practical, tech-based strategy to help liver transplant patients stick to their medication schedule, potentially reducing complications and improving long-term health.
What could go wrong
This is a behavioral study, not a drug trial, so it won't directly treat the disease. Results depend on patient engagement and may not apply to all populations or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

361 people

The number who actually took part.

Started

Dec 2022

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Liver Transplant Recipient Inclusion Criteria: * 18 years or older * Within 3 months of liver transplant * English or Spanish-speaking * Home-dwelling\* * Patient or care partner owns a smart phone and is comfortable receiving text messages and/or using the internet on the smart phone. * \*The definition of "home" includes hotel or short-term housing. Patients who are going to a rehabilitation or skilled nursing facility (SNF) immediately after transplant may still be recruited if the site-PI/Co-I determines they are likely to be discharged to home within 3 months post-transplant. Care Partner Inclusion Criteria: * 18 years or older * English or Spanish speaking * Care partner has access to a smart phone and is comfortable receiving text messages and/or using the internet on the smart phone. Liver Transplant Recipient Exclusion Criteria: * Liver transplant recipient who speaks neither English nor Spanish * Any severe uncorrectable vision, hearing, or cognitive impairments that may impede study interviews Care Partner Exclusion Criteria: * Care partner who speaks neither English nor Spanish

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cirrhosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic liver failure cirrhosis of liver End Stage Liver Disease Fibrosis Medication Adherence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cirrhosis End-stage liver disease Liver transplant; complications Medication adherence

Contacts and locations

Locations

  • Northwestern University

    Chicago, Illinois, 60208, United States

  • University of Miami

    Miami, Florida, 33146, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.